Sartorius Stedim Biotech SA
PAR:DIM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
PAR:DIM
|
FR |
|
X
|
Xenon Pharmaceuticals Inc
SWB:XP0
|
CA |
|
S
|
Sanofi SA
BMV:SNYN
|
FR |
|
Basf Se
MIL:1BAS
|
DE |
|
M
|
Mckesson Corp
XMUN:MCK
|
US |
|
T
|
Tamarack Valley Energy Ltd
F:9TA1
|
CA |
|
F
|
Funko Inc
SWB:FU2
|
US |
Wall St Price Targets
DIM Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for DIM is 235.7 EUR with a low forecast of 212.1 EUR and a high forecast of 275.1 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DIM's stock price target?
Price Target
235.7
EUR
According to Wall Street analysts, the average 1-year price target for DIM is 235.7 EUR with a low forecast of 212.1 EUR and a high forecast of 275.1 EUR.
What is the Revenue forecast for Sartorius Stedim Biotech SA?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Sartorius Stedim Biotech SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 5 years is 13%.
What is the Operating Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Pre-Tax Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
36%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 36%.
What is the Net Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 24%.
